BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Expec

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Expected to Announce Quarterly Sales of $41.84 Million

Wall Street analysts expect that BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) will post sales of $41.84 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for BioDelivery Sciences International’s earnings, with estimates ranging from $41.00 million to $42.60 million. BioDelivery Sciences International posted sales of $42.17 million in […]

Related Keywords

James Vollins , Life Insurance Co , Zacks Investment Research , Janney Montgomery Scott , Biodelivery Sciences International , Nasdaq , Cantor Fitzgerald , Biodelivery Sciences International Inc , Barclays Plc , Biodelivery Sciences International Company Profile Get Rating , Wall Street , Get Rating , Delivery Sciences International , Biodelivery Sciences , Montgomery Scott , Delivery Sciences International Company Profile , Nasdaq Bdsi , Bdsi , Medical , 09060j10 , Ratings , Consensus ,

© 2025 Vimarsana